New malaria vaccine depends on ... mosquito bites

Feb 16, 2011 By Keith Brannon
Professor Nirbhay Kumar will produce and test a novel malaria vaccine to inoculate mosquitoes when they bite people.

The same menace that spreads malaria – the mosquito bite – could help wipe out the deadly disease, according to researchers working on a new vaccine at Tulane University.

The PATH Malaria Vaccine Initiative (MVI), established in 1999 through a grant from the Bill & Melinda Gates Foundation, announced today a collaboration with Tulane University School of Public Health and Tropical Medicine and India’s Gennova Biopharmaceuticals Ltd. to produce and test a novel vaccine that aims to inoculate mosquitoes when they bite people.

The vaccine would work by triggering an immune response in people so they produce antibodies that target a protein the malaria parasite needs to reproduce within a mosquito.

Malaria, which kills nearly 800,000 people every year worldwide, is caused by a microscopic parasite that alternates between human and mosquito hosts at various stages of its lifecycle. Once a mosquito bites a vaccinated person, the antibodies would neutralize the protein essential for malaria parasite’s reproduction, effectively blocking the parasite’s – and the mosquito’s – ability to infect others.

The vaccine relies on a protein — known as Pfs48/45 — which is very difficult to synthetically produce, says Nirbhay Kumar, professor of tropical medicine at Tulane.

“With MVI’s support we can now work with Gennova to produce sufficient quantity of the protein and develop a variety of vaccine formulations that can be tested in animals to determine which one give us the strongest immune response,” Kumar says.

Such transmission blocking vaccines, though not yet widely tested in humans, are attracting widespread interest due to their potential to be used in conjunction with more traditional malaria vaccines and other interventions—such as malaria drugs and bed nets—to make gradual elimination and even eradication of the disease a reality.

“We’re investing in developing transmission blocking malaria vaccines to support two long-term goals: introducing an 80 percent efficacious malaria vaccine by the year 2025 and eventually eradicating malaria altogether,” says Dr. Christian Loucq, director of MVI. “A that breaks the cycle of transmission will be important to our success.”

Explore further: New conversion process turns biomass 'waste' into lucrative chemical products (w/ Video)

add to favorites email to friend print save as pdf

Related Stories

Vaccine blocks malaria transmission in lab experiments

Jul 22, 2009

Researchers at the Johns Hopkins Malaria Research Institute have for the first time produced a malarial protein (Pfs48/45) in the proper conformation and quantity to generate a significant immune response in mice and non-human ...

Gates: $258 million for malaria research

Oct 31, 2005

The Bill and Melinda Gates Foundation has given $258 million in malaria research grants. The foundation says malaria kills an estimated 2,000 African children each day and takes the lives of more than 1 million people wor ...

Recommended for you

Quest to unravel mysteries of our gene network

9 hours ago

There are roughly 27,000 genes in the human body, all but a relative few of them connected through an intricate and complex network that plays a dominant role in shaping our physiological structure and functions.

EU court clears stem cell patenting

11 hours ago

A human egg used to produce stem cells but unable to develop into a viable embryo can be patented, the European Court of Justice ruled on Thursday.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

hush1
not rated yet Feb 26, 2011
This would not give any protective benefits to the individual inoculated.

If you do not state these eleven words, you jeopardize the entire endeavor and all those associated with the undertaking.

Eleven words. Deliberate.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.